Efficacy and tolerability of benzodiazepines for the treatment of behavioral and psychological symptoms of dementia: a systematic review of randomized controlled trials (Q38304559)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Efficacy and tolerability of benzodiazepines for the treatment of behavioral and psychological symptoms of dementia: a systematic review of randomized controlled trials	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

1 reference

Europe PubMed Central

Efficacy and tolerability of benzodiazepines for the treatment of behavioral and psychological symptoms of dementia: a systematic review of randomized controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Rajesh R Tampi

1

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Deena J Tampi

2

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

language of work or name

0 references

publication date

1 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

American Journal of Alzheimer's Disease & Other Dementias

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

565-574

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

The prevalence of benzodiazepine dependence among community-dwelling older adult users in Quebec according to typical and atypical criteria

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Factors associated with benzodiazepine dependence among community-dwelling seniors

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Trends in psychotropic medication use among U.S. adults

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Benzodiazepine prescribing in elderly Australian general practice patients.

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Psychotropics use in the Spanish elderly: predictors and evolution between years 1993 and 2003.

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use.

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

The epidemiology of long-term benzodiazepine use.

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Assessment of behavioral and psychological symptoms of dementia

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale.

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Incontinence and troublesome behaviors predict institutionalization in dementia

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

The incremental direct costs associated with behavioral symptoms in AD.

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia.

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Management of agitation and aggression associated with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Antipsychotic and Benzodiazepine Use Among Nursing Home Residents: Findings From the 2004 National Nursing Home Survey

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Alleviating agitation, apprehension, and related symptoms in geriatric patients: A double-blind comparison of a phenothiazine and a benzodiazepien

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients.

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Alprazolam as an alternative to low-dose haloperidol in older, cognitively impaired nursing facility patients.

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

QT alterations in psychopharmacology: proven candidates and suspects

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Inappropriateness of medication prescriptions to elderly patients in the primary care setting: a systematic review

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

The role of benzodiazepines in the treatment of insomnia: meta-analysis of benzodiazepine use in the treatment of insomnia

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Meta-analysis of the impact of 9 medication classes on falls in elderly persons

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Association between use of benzodiazepines and risk of fractures: a meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Cognitive Effects of Long-Term Benzodiazepine Use

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Benzodiazepine use and risk of dementia: prospective population based study

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Economic impact of inappropriate benzodiazepine prescribing and related drug interactions among elderly persons

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Efficacy and tolerability of antidepressants in the treatment of behavioral and psychological symptoms of dementia, a literature review of evidence

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Drug-induced liver injury: present and future

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Atypical antipsychotic drugs in the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Treating neuropsychiatric symptoms in dementia with Lewy bodies: a randomized controlled-trial.

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Psychotropic medications and the risk of sudden cardiac death during an acute coronary event

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

QTc prolongation, torsades de pointes, and psychotropic medications

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Assessment and treatment of alcoholism and substance-related disorders in the elderly

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Geriatric psychopharmacology: evolution of a discipline

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Adverse effects of atypical antipsychotics in the elderly: a review

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms

1 reference

https://api.crossref.org/works/10.1177%2F1533317514524813

21 January 2018

Identifiers

10.1177/1533317514524813

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38304559&oldid=1752762805"